ArticleInternational journal of clinical and experimental pathology2017
Plexiform fibromyxoma of the stomach: a clinicopathological study of 10 cases.
Article in International journal of clinical and experimental pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.
- Pooled it
- Plexiform fibromyxoma of the lesser curvature of the stomach in a 16-year-old adolescent: A case report and literature review.Experimental and therapeutic medicine · 2026Article
- Giant plexiform fibromyxoma of the esophagus.Wiener klinische Wochenschrift · 2026Article
- Successful preoperative diagnosis and laparoscopic endoscopic cooperative surgery for gastric plexiform fibromyxoma: a case report.Clinical journal of gastroenterology · 2026Article
- Plexiform Fibromyxoma with MALAT1-GLI1 Fusion with Limited Myxoid Stroma, Aberrant KIT Expression, and Diffuse D2-40 Expression: A Case Report.Diagnostics (Basel, Switzerland) · 2026Article
- Smooth muscle actin (SMA)-negative uninodular plexiform fibromyxoma: case report of a challenging atypical presentation of a rare gastric mesenchymal tumor in a 25-year-old female.AME case reports · 2026Article
- Plexiform Fibromyxoma in the Stomach: Immunohistochemical Profile and Comprehensive Genetic Characterization.International journal of molecular sciences · 2024Article
- Endoscopic submucosal excavation for gastric plexiform fibromyxoma: A case report and systematic review of literature.Frontiers in oncology · 2023Article
- Plexiform angiomyxoid myofibroblastic tumor treated by endoscopic submucosal dissection: A case report and review of the literature.World journal of gastroenterology · 2021Review
- Plexiform fibromyxoma: a clinicopathological and immunohistochemical analysis of two cases with a literature review.The Journal of international medical research · 2021Review
- Gastric Plexiform Fibromyxoma with Two Different Growth Patterns on Histological Images: a Case Report.Journal of gastric cancer · 2021Article
- Plexiform fibromyxoma: Review of rare mesenchymal gastric neoplasm and its differential diagnosis.World journal of gastrointestinal oncology · 2021Review
- An Update on Clinicopathological and Molecular Features of Plexiform Fibromyxoma.Canadian journal of gastroenterology & hepatology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plexiform fibromyxoma (PF) is a unique mesenchymal tumor of the stomach. The molecular characteristics of these tumors remain unclear. Here, we report 10 cases of PF with clinicopathological features and molecular features in detail. The patients ranged in age from 26 to 72 years (mean, 49 y) and most commonly presented with abdominal pain and distension, black stool, and anemia. Eight tumors were located at the antrum while two in the fundus of stomach. Histologically, tumor cells exhibited a plexiform growth pattern with multiple nodules in the muscularis propria of stomach wall and infiltrative borders. Immunohistochemically, all tumors were strongly positive for vimentin and smooth muscle actin (SMA), some were staining for CD10 (5/10), desmin (5/10), H-caldesmon (6/10) and progesterone receptor (PR, 6/10), however, CD34, S-100, Estrogen Receptor (ER), ALK, CD117 and DOG-1 were all negative in our cases. The glioma-associated oncogene homologue 1 (
Indexed as
Identifiers
31966436PMC6965819W3026883336What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.